Literature DB >> 23109644

Calcium and phosphate impact cardiovascular risk.

Gunnar H Heine1, Masaomi Nangaku, Danilo Fliser.   

Abstract

Non-traditional risk factors substantially contribute to cardiovascular (CV) disease. A deranged calcium-phosphate metabolism-first identified as a major non-traditional CV risk factor in patients with chronic kidney disease-may be implicated in development and progression of CV disease even among individuals with intact renal function. This review thus summarizes epidemiological and experimental data on the role of calcium, phosphate, and its major regulating hormones-parathyroid hormone, calcitriol, and fibroblast growth factor 23-in CV medicine.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23109644     DOI： 10.1093/eurheartj/ehs353

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  15 in total

1.  High Circulatory Phosphate Level Is Associated with Cerebral Small-Vessel Diseases.

Authors:  Chih-Ping Chung; Li-Ning Peng; Kun-Hsien Chou; Li-Kuo Liu; Wei-Ju Lee; Ching-Po Lin; Liang-Kung Chen; Pei-Ning Wang
Journal:  Transl Stroke Res       Date:  2018-06-25       Impact factor: 6.829

2.  Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

Authors:  Sarah Seiler; Kyrill S Rogacev; Heinz J Roth; Pagah Shafein; Insa Emrich; Stefan Neuhaus; Jürgen Floege; Danilo Fliser; Gunnar H Heine
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 8.237

3.  Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis.

Authors:  Hazan Karadeniz; Aslıhan Avanoğlu Güler; Gülce Koca; Reyhan Bilici Salman; Hasan Satış; Nuh Ataş; Hakan Babaoğlu; Hatice Paşaoğlu; Hamit Küçük; Abdurrahman Tufan; Mehmet Akif Öztürk; Berna Göker; Şeminur Haznedaroğlu
Journal:  Clin Rheumatol       Date:  2022-01-11       Impact factor: 2.980

Review 4.  Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy.

Authors:  Mridul Datta; Gary G Schwartz
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-07       Impact factor: 6.312

5.  FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock.

Authors:  Janine Pöss; Felix Mahfoud; Sarah Seiler; Gunnar H Heine; Danilo Fliser; Michael Böhm; Andreas Link
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09

Review 6.  The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart.

Authors:  Kevin Chan; Sharon M Moe; Rajiv Saran; Peter Libby
Journal:  Eur Heart J       Date:  2021-03-31       Impact factor: 29.983

7.  Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Authors:  Georg Fuernau; Janine Pöss; Daniel Denks; Steffen Desch; Gunnar H Heine; Ingo Eitel; Sarah Seiler; Suzanne de Waha; Sebastian Ewen; Andreas Link; Gerhard Schuler; Volker Adams; Michael Böhm; Holger Thiele
Journal:  Crit Care       Date:  2014-12-21       Impact factor: 9.097

8.  The association between circulating IGF1, IGFBP3, and calcium: results from NHANES III.

Authors:  Mieke Van Hemelrijck; Thurkaa Shanmugalingam; Cecilia Bosco; Wahyu Wulaningsih; Sabine Rohrmann
Journal:  Endocr Connect       Date:  2015-09       Impact factor: 3.335

9.  PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR.

Authors:  Kyrill S Rogacev; Gunnar H Heine; Günther Silbernagel; Marcus E Kleber; Sarah Seiler; Insa Emrich; Simone Lennartz; Christian Werner; Adam M Zawada; Danilo Fliser; Michael Böhm; Winfried März; Hubert Scharnagl; Ulrich Laufs
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes.

Authors:  Ting-Wei Lee; Ting-I Lee; Yung-Kuo Lin; Yu-Hsun Kao; Yi-Jen Chen
Journal:  J Biomed Sci       Date:  2018-05-18       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.